These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6682362)

  • 41. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
    Laskin OL; de Miranda P; King DH; Page DA; Longstreth JA; Rocco L; Lietman PS
    Antimicrob Agents Chemother; 1982 May; 21(5):804-7. PubMed ID: 7103460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.
    Nadai M; Apichartpichean R; Hasegawa T; Nabeshima T
    J Pharm Sci; 1992 Oct; 81(10):1024-7. PubMed ID: 1432614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal tubular secretion and reabsorption as factors in ochratoxicosis: effects of probenecid on nephrotoxicity.
    Stein AF; Phillips TD; Kubena LF; Harvey RB
    J Toxicol Environ Health; 1985; 16(3-4):593-605. PubMed ID: 4087321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereoselective renal tubular secretion of carbenicillin.
    Itoh T; Ishida M; Onuki Y; Tsuda Y; Shimada H; Yamada H
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2327-32. PubMed ID: 8285614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
    Wang JP; Unadkat JD; al-Habet SM; O'Sullivan TA; Williams-Warren J; Smith AL; Ramsey B
    Clin Pharmacol Ther; 1993 Sep; 54(3):293-302. PubMed ID: 8375124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus.
    Sjövall J; Karlsson A; Ogenstad S; Sandström E; Saarimäki M
    Clin Pharmacol Ther; 1988 Jul; 44(1):65-73. PubMed ID: 2968875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Saturation of the tubular excretion of beta-lactam antibiotics.
    Bins JW; Mattie H
    Br J Clin Pharmacol; 1988 Jan; 25(1):41-50. PubMed ID: 3370191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration.
    Wong SL; Hedaya MA; Sawchuk RJ
    Pharm Res; 1992 Feb; 9(2):228-35. PubMed ID: 1553347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of probenecid and N'-methylnicotinamide on renal handling of cis-dichlorodiammineplatinum-II in rats.
    Osman NM; Litterst CL
    Cancer Lett; 1983 May; 19(1):107-11. PubMed ID: 6221790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of renal clearance of neopterin by a pharmacokinetic approach.
    Estelberger W; Weiss G; Petek W; Paletta B; Wachter H; Reibnegger G
    FEBS Lett; 1993 Aug; 329(1-2):13-6. PubMed ID: 8354387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extensive tubular secretion and reabsorption of creatinine in humans.
    Sjöström PA; Odlind BG; Wolgast M
    Scand J Urol Nephrol; 1988; 22(2):129-31. PubMed ID: 3206217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal clearance of temocillin in volunteers.
    Overbosch D; van Gulpen C; Mattie H
    Drugs; 1985; 29 Suppl 5():128-34. PubMed ID: 4029016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologically based pharmacokinetic model for beta-lactam antibiotics I: Tissue distribution and elimination in rats.
    Tsuji A; Yoshikawa T; Nishide K; Minami H; Kimura M; Nakashima E; Terasaki T; Miyamoto E; Nightingale CH; Yamana T
    J Pharm Sci; 1983 Nov; 72(11):1239-52. PubMed ID: 6644585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal handling of cisplatin: interactions with organic anions and cations in the dog.
    Klein J; Bentur Y; Cheung D; Moselhy G; Koren G
    Clin Invest Med; 1991 Oct; 14(5):388-94. PubMed ID: 1742916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal handling of zomepirac sodium (McN-2783-21-98) in the rat.
    O'Neill PJ; Yorgey KA; Migdalof BH; Gussin RZ
    J Pharmacol Exp Ther; 1979 Jun; 209(3):366-70. PubMed ID: 35605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J; Thabaut A; Meyran M; Acar JF; Kitzis MD; Chanal M; Cluzel M; Morel C
    Pathol Biol (Paris); 1983 Jun; 31(6):488-91. PubMed ID: 6348655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.